113 related articles for article (PubMed ID: 22659407)
21. Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice.
Lennox R; Porter DW; Flatt PR; Holscher C; Irwin N; Gault VA
Neuropharmacology; 2014 Nov; 86():22-30. PubMed ID: 24998752
[TBL] [Abstract][Full Text] [Related]
22. Synaptic capture-mediated long-lasting long-term potentiation is strongly dependent on mRNA translation.
Ris L; Villers A; Godaux E
Neuroreport; 2009 Nov; 20(17):1572-6. PubMed ID: 19841599
[TBL] [Abstract][Full Text] [Related]
23. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function.
Vannini E; Olimpico F; Middei S; Ammassari-Teule M; de Graaf EL; McDonnell L; Schmidt G; Fabbri A; Fiorentini C; Baroncelli L; Costa M; Caleo M
Neuro Oncol; 2016 Dec; 18(12):1634-1643. PubMed ID: 27298309
[TBL] [Abstract][Full Text] [Related]
25. How to analyze bacterial toxins targeting Rho GTPases.
Bielek H; Schmidt G
Methods Mol Biol; 2012; 827():59-75. PubMed ID: 22144267
[TBL] [Abstract][Full Text] [Related]
26. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model.
Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M
BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046
[TBL] [Abstract][Full Text] [Related]
27. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology.
Lemonnier M; Landraud L; Lemichez E
FEMS Microbiol Rev; 2007 Sep; 31(5):515-34. PubMed ID: 17680807
[TBL] [Abstract][Full Text] [Related]
28. The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey.
Smith SM; Uslaner JM; Cox CD; Huszar SL; Cannon CE; Vardigan JD; Eddins D; Toolan DM; Kandebo M; Yao L; Raheem IT; Schreier JD; Breslin MJ; Coleman PJ; Renger JJ
Neuropharmacology; 2013 Jan; 64():215-23. PubMed ID: 22750078
[TBL] [Abstract][Full Text] [Related]
29. A new member of a growing toxin family--Escherichia coli cytotoxic necrotizing factor 3 (CNF3).
Stoll T; Markwirth G; Reipschläger S; Schmidt G
Toxicon; 2009 Nov; 54(6):745-53. PubMed ID: 19520097
[TBL] [Abstract][Full Text] [Related]
30. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD
Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305
[TBL] [Abstract][Full Text] [Related]
31. The NMDA receptor as a target for cognitive enhancement.
Collingridge GL; Volianskis A; Bannister N; France G; Hanna L; Mercier M; Tidball P; Fang G; Irvine MW; Costa BM; Monaghan DT; Bortolotto ZA; Molnár E; Lodge D; Jane DE
Neuropharmacology; 2013 Jan; 64():13-26. PubMed ID: 22796429
[TBL] [Abstract][Full Text] [Related]
32. Ghrelin controls hippocampal spine synapse density and memory performance.
Diano S; Farr SA; Benoit SC; McNay EC; da Silva I; Horvath B; Gaskin FS; Nonaka N; Jaeger LB; Banks WA; Morley JE; Pinto S; Sherwin RS; Xu L; Yamada KA; Sleeman MW; Tschöp MH; Horvath TL
Nat Neurosci; 2006 Mar; 9(3):381-8. PubMed ID: 16491079
[TBL] [Abstract][Full Text] [Related]
33. E. coli CNF1 toxin: a two-in-one system for host-cell invasion.
Landraud L; Pulcini C; Gounon P; Flatau G; Boquet P; Lemichez E
Int J Med Microbiol; 2004 Apr; 293(7-8):513-8. PubMed ID: 15149026
[TBL] [Abstract][Full Text] [Related]
34. Differences between synaptic plasticity thresholds result in new timing rules for maximizing long-term potentiation.
Lynch G; Kramár EA; Babayan AH; Rumbaugh G; Gall CM
Neuropharmacology; 2013 Jan; 64(1):27-36. PubMed ID: 22820276
[TBL] [Abstract][Full Text] [Related]
35. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
Moriguchi S; Yamamoto Y; Ikuno T; Fukunaga K
J Neurochem; 2011 Jun; 117(5):879-91. PubMed ID: 21434925
[TBL] [Abstract][Full Text] [Related]
36. Protective action of mithramycin against neurodegeneration and impairment of synaptic plasticity in the hippocampal CA1 area after transient global ischemia.
Osada N; Kosuge Y; Oguchi S; Miyagishi H; Ishige K; Ito Y
Neurochem Int; 2012 Jan; 60(1):47-54. PubMed ID: 22100565
[TBL] [Abstract][Full Text] [Related]
37. Effects of the
Carlini F; Maroccia Z; Fiorentini C; Travaglione S; Fabbri A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830494
[TBL] [Abstract][Full Text] [Related]
38. Bacopa monnieri extract enhances learning-dependent hippocampal long-term synaptic potentiation.
Promsuban C; Limsuvan S; Akarasereenont P; Tilokskulchai K; Tapechum S; Pakaprot N
Neuroreport; 2017 Nov; 28(16):1031-1035. PubMed ID: 28885486
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
Gingras D; Lamy S; Béliveau R
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
[TBL] [Abstract][Full Text] [Related]
40. Structural elements required for deamidation of RhoA by cytotoxic necrotizing factor 1.
Buetow L; Ghosh P
Biochemistry; 2003 Nov; 42(44):12784-91. PubMed ID: 14596592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
